Adam Raben, MD

Specialty
Radiation Oncology

Dr. Raben is a graduate of Duke University and a 1990 graduate of Wake Forest University School of Medicine. During medical school, he was a visiting scholar and basic science researcher in 1989 in the Department of Radiation Oncology at Addenbrooke’s Hospital through Cambridge University in Cambridge, England. Dr. Raben completed residency training in Radiation Oncology at Memorial Sloan-Kettering Cancer Center from 1991 to 1993 and served as chief resident from 1993 to1994. He received specialty training in brachytherapy during residency. Dr. Raben was a faculty Member in the Department of Radiation Oncology at Memorial Sloan-Kettering from 1994 to 1998. He co-authored the Lung Cancer chapter in DeVita’s Principles and Practice of Oncology in 1996. He is also a co-author of numerous national publications related to the treatment of head, neck, lung and prostate cancer.

Dr. Raben was recruited and appointed Chairman of Radiation Oncology at Monmouth Medical Center in Long Branch, N.J. in 1998 and directed the program until 2003. During this time, he developed a comprehensive prostate brachytherapy program. He was responsible for the introduction of Intensity Modulated Radiation Therapy (IMRT), an advanced form of conformal radiation, at Monmouth Medical Center and at the Helen F. Graham Cancer Center & Research Institute.

Dr. Raben was awarded the prestigious Gallo Award through the Cancer Institute of New Jersey from 1999 to 2002 for clinical research in the treatment of prostate cancer and IMRT. Dr. Raben is a member of the American Society for Therapeutic Radiology and Oncology, the American College of Radiation Oncology. He is the principal research director at the Graham Cancer Center for the Radiation Therapy Oncology Group (RTOG) and Department of Radiation Oncology and has garnered several awards for patient trial accruals. Dr. Raben currently serves on the NCI steering committee for Head and Neck Clinical trials and is currently a member of the NCORP-CCDR committee for trial design within the NRG. He has expertise and interest in the management of head, neck, lung and prostate cancer, skin and more recently in the use of targeted therapy for head and neck cancer. Dr. Raben became board certified by the American College of Radiology in 1995 and re-certified in 2005, and 2015.